Press Releases

EIN Presswire

The Business Research Company's Artificial Intelligence (AI) Protein Structure Prediction Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2026 /⁨EINPresswire.com⁩/ -- "The field of...

EIN Presswire

Food Storage Container Market to reach US$199.9 Bn by 2033 at 4.3% CAGR, driven by demand for hygienic, reusable, and sustainable storage.

Governor of State of Hawaii

STATE OF HAWAIʻI KA MOKU ʻĀINA O HAWAIʻI JOSH GREEN, M.D. GOVERNOR KE KIAʻĀINA GOVERNOR GREEN UNVEILS 2026 POLICY REPORT TITLED “A VISION FOR HAWAI‘I’S FUTURE” FOR IMMEDIATE RELEASE May 14, 2026 HONOLULU – Governor Josh Green today announced a new...

City and County of Honolulu - Hawaii

HONOLULU – The City and County of Honolulu’s Office of Climate Change, Sustainability and Resiliency (CCSR), in partnership with the Hawaiʻi Good Food Alliance (HGFA), has completed two multi-year initiatives aimed at expanding access to federal...

Governor of State of Hawaii

STATE OF HAWAIʻI KA MOKU ʻĀINA O HAWAIʻI JOSH GREEN, M.D. GOVERNOR KE KIAʻĀINA GOVERNOR GREEN UNVEILS 2026 POLICY REPORT TITLED “A VISION FOR HAWAI‘I’S FUTURE” FOR IMMEDIATE RELEASE May 14, 2026 HONOLULU – Governor Josh Green today announced a new...

GlobeNewswire, Inc.

VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today it will report its financial results for the second quarter ended March 31, 2026 on Thursday, May...

GlobeNewswire, Inc.

VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) -- American Hotel Income Properties REIT LP (“AHIP”, or the “Company”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB. V), today announced its financial results for the three months ended March 31,...

EIN Presswire

The global pet food market to grow from US$131.2 billion in 2026 to US$215.5 billion by 2033, expanding at a 5.6% CAGR during 2026–2033 forecast period BRENTFORD, ENGLAND, UNITED KINGDOM, May 14, 2026 /⁨EINPresswire.com⁩/ -- The global pet food...

GlobeNewswire, Inc.

Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring (CBGM) technology Company targeting U.S....

Office of the Deputy Mayor for Planning and Economic Development - Washington D.C.

(Washington, DC) – Today, Mayor Muriel Bowser joined community members, District leaders, and representatives of the Skyland Development Team to cut the ribbon on a new community park at Skyland Town Center.

GlobeNewswire, Inc.

- Reported positive FDA Type 2a meeting supporting ABP-450’s comparative analytical strategy under the 351(k) regulatory pathway - - Strengthened balance sheet through financing transactions and Daewoong note exchange, reducing outstanding debt by...

GlobeNewswire, Inc.

Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress.

GlobeNewswire, Inc.

PHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics...

GlobeNewswire, Inc.

Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing Commencement and Flora Sync LF5™ Commercial Launch Summer 2026; First Product Revenue Expected in June 2026;...

GlobeNewswire, Inc.

Enhanced the company’s portfolio with an exclusive license for, CUE-221, a Phase 2 program targeting allergic disease Hosted virtual R&D day showcasing CUE-401, a bifunctional IL-2 and TGF-B program targeting autoimmune disease Strengthened the...

GlobeNewswire, Inc.

Final Data from Phase 2 Expansion Study of NUC-7738 Expected in 2026 NUC-7738 Receives FDA IND Clearance: Planned Initial Studies to Focus on Melanoma Advancing Additional Indications and Combination Strategies Cash Runway Expected to Extend into...

GlobeNewswire, Inc.

Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total Revenue Active Commercial Cancer Center Customers Expand to 16 with Growing Sales Pipeline, Accelerating Adoption of the TAMP™ Therapy Platform Enabled by the RenovoCath® Device...

GlobeNewswire, Inc.

Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027. Topline 12-month data from the BIM-IOL System Phase 1/2 trial demonstrated...

GlobeNewswire, Inc.

NXT-41 review advancing collaboratively with FDA, informing NXT-41x submission preparations Brought a new automated manufacturing process online, supporting a gross margin target of more than 80% at scale Chief Commercial Officer Pete Ligotti's...

GlobeNewswire, Inc.

Completed successful End-of-Phase 2 meeting with the FDA and selected onvansertib dose and chemotherapy regimen for planned Phase 3 trial Company to provide detailed data update from Phase 2 CRDF-004 trial in rapid oral presentation at American...